Article
Topoisomerase II and leukemia
3 Feb 2014
Abstract excerpt
Type II topoisomerases are essential enzymes that modulate DNA under- and overwinding, knotting, and tangling. Beyond their critical physiological functions, these enzymes are the targets for some of the most widely prescribed anticancer drugs (topoisomerase II poisons) in clinical use. Topoisomerase II poisons kill cells by increasing levels of covalent enzyme-cleaved DNA complexes that are normal reaction...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
